Obesity may have met its match in GLP-1 receptor agonists. However, the role of gastroenterologists in obesity management and ...

GLP-1 RA use is associated with a lower risk of developing Parkinson disease compared with sulfonylurea use in a large cohort study.

Activating the GPR133 receptor with a small molecule can rebuild bone from within, offering a new direction for osteoporosis ...

New breast cancer pill eliminates tumor proteins and improves treatment response in patients by making the estrogen receptor ...

Serotonin receptor agonists are a group of medications that activate the serotonin receptors in the central nervous system. A low serotonin level can lead to difficulty sleeping, depression, anxiety, ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

The way that the sense of smell works is that olfactory sensory neurons (OSNs) are wired up to olfactory receptors (ORs) in ...